Vaccine News – VAXXED TV – Your facebook posts are making a difference & Study – Eczema vaccinatum resulting from the transmission of vaccinia virus from a smallpox vaccinee: an investigation of potential fomites in the home environment

US National Library of Medicine
National Institutes of Health – Apr 2012

Study – Differentiating the wild from the attenuated during a measles outbreak

Nestibo L, Lee BE, Fonseca K, Beirnes J, Johnson MM, Sikora CA.
Author information
Communicable Disease Control, Alberta Health Services;

Abstractin
In the midst of a local measles outbreak, a recently immunized child was investigated for a new-onset measles-type rash. Nucleic acid testing identified that a vaccine-type measles virus was being shed in the urine. Clinically differentiating measles from a nonmeasles rash is challenging, but can be supported by a thorough medical history evaluation. Rashes are expected to occur after immunization; nucleic acid testing can be used when it is difficult to differentiate between wild and attenuated strains.

US National Library of Medicine
National Institutes of Health – Jan 2009

Study – Eczema vaccinatum resulting from the transmission of vaccinia virus from a smallpox vaccinee: an investigation of potential fomites in the home environment.

Lederman E, Miramontes R, Openshaw J, Olson VA, Karem KL, Marcinak J, Panares R, Staggs W, Allen D, Weber SG, Vora S, Gerber SI, Hughes CM, Regnery R, Collins L, Diaz PS, Reynolds MG, Damon I.
Author information
Poxvirus and Rabies Branch, Division of Viral and Rickettsial Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA. edith.lederman@med.navy.mil

Abstract
On March 3, 2007, a 2-year-old boy was hospitalized with eczema vaccinatum. His two siblings, one with eczema, were subsequently removed from the home. Swabs of household items obtained on March 13th were analyzed for orthopoxvirus DNA signatures with real-time PCR. Virus culture was attempted on positive specimens. Eight of 25 household samples were positive by PCR for orthopoxvirus; of these, three yielded viable vaccinia virus in culture. Both siblings were found to have serologic evidence of orthopoxvirus exposure. These findings have implications for smallpox preparedness, especially in situations where some household members are not candidates for vaccination.

US National Library of Medicine
National Institutes of Health – Jan 2005

Study – Effect of different immunisation schedules on the excretion and reversion of oral poliovaccine strains.

Minor PD, Dunn G, Ramsay ME, Brown D.
Author information
National Institute for Biological Standards and Control, Blanche Lane South Mimms, Potters Bar, Herts, EN6 3QG, UK. pminor@nibsc.ac.uk

Abstract
Excretion of live oral poliovaccine and molecular markers of increased virulence in the viruses isolated were examined in children who were either previously immunised with inactivated or live vaccine or were unimmunised. There appeared to be some effect of previous immunisation with either live or killed vaccine at the second dose of live vaccine. Where an effect was seen it took the form of reduced rates of excretion, shorter time periods of excretion and more rapid and complete reversion of the excreted virus. The data are consistent with the view that poliovirus is able to escape the immune pressure in the gut to some extent by improving its general fitness rather than direct evasion of immunity.

VAXXED TV – These 3 Moms, The 1st of Many

What does this law mean for your family?

Learn to bypass your own obstacles

How can you fight that?

What Causes “Lazy Eye”?

Right then I knew they were all lying

It’s not like this in Germany

Are these vaccines safe?

Your facebook posts are making a difference

Addressing ridiculous topics #peepsTV #Praybig

****************************************************

FOR ISRAEL Ministry – Jewish Johnathan Ben-David forgave his killer and you would not believe why!!!

How to accept Jesus Christ as your personal Saviour

Testimony by Phil Robertson from Duck Dynasty

1 Corinthians 15 Authorized (King James) Version (AKJV)
1 Moreover, brethren, I declare unto you the gospel which I preached unto you, which also ye have received, and wherein ye stand;
2 by which also ye are saved, if ye keep in memory what I preached unto you, unless ye have believed in vain.
3 For I delivered unto you first of all that which I also received, how that Christ died for our sins according to the scriptures;
4 and that he was buried, and that he rose again the third day according to the scriptures:

Hebrews 6 Authorized (King James) Version (AKJV)
1 Therefore leaving the principles of the doctrine of Christ, let us go on unto perfection; not laying again the foundation of repentance from dead works, and of faith toward God,
2 of the doctrine of baptisms, and of laying on of hands, and of resurrection of the dead, and of eternal judgment.
3 And this will we do, if God permit.
4 For it is impossible for those who were once enlightened, and have tasted of the heavenly gift, and were made partakers of the Holy Ghost,
5 and have tasted the good word of God, and the powers of the world to come,
6 if they shall fall away, to renew them again unto repentance; seeing they crucify to themselves the Son of God afresh, and put him to an open shame.
7 For the earth which drinketh in the rain that cometh oft upon it, and bringeth forth herbs meet for them by whom it is dressed, receiveth blessing from God:
8 but that which beareth thorns and briers is rejected, and is nigh unto cursing; whose end is to be burned.

Isaiah 53 – Old testament Prophecy about Jesus

1 Who hath believed our report? and to whom is the arm of the Lord revealed?
2 For he shall grow up before him as a tender plant,and as a root out of a dry ground:he hath no form nor comeliness;and when we shall see him,there is no beauty that we should desire him.
3 He is despised and rejected of men;a man of sorrows, and acquainted with grief:and we hid as it were our faces from him;he was despised, and we esteemed him not.
4 Surely he hath borne our griefs,and carried our sorrows:yet we did esteem him stricken,smitten of God, and afflicted.
5 But he was wounded for our transgressions,he was bruised for our iniquities:the chastisement of our peace was upon him;and with his stripes we are healed.
6 All we like sheep have gone astray;we have turned every one to his own way;and the Lord hath laid on him the iniquity of us all.
7 He was oppressed, and he was afflicted,yet he opened not his mouth:he is brought as a lamb to the slaughter,and as a sheep before her shearers is dumb,so he openeth not his mouth.
8 He was taken from prison and from judgment:and who shall declare his generation? for he was cut off out of the land of the living:for the transgression of my people was he stricken.
9 And he made his grave with the wicked,and with the rich in his death;because he had done no violence,neither was any deceit in his mouth.
10 Yet it pleased the Lord to bruise him;he hath put him to grief:when thou shalt make his soul an offering for sin,he shall see his seed, he shall prolong his days,and the pleasure of the Lord shall prosper in his hand.
11 He shall see of the travail of his soul, and shall be satisfied:by his knowledge shall my righteous servant justify many;for he shall bear their iniquities.
12 Therefore will I divide him a portion with the great,and he shall divide the spoil with the strong;because he hath poured out his soul unto death:and he was numbered with the transgressors;and he bare the sin of many,and made intercession for the transgressors.

The Only Sin That Leads To Hell – Kenneth E Hagin

 

Vaccine News – VAXXED TV – What I Know Now & Scientists Prove Those Vaccinated for Shingles Can Infect Others with Chicken Pox

Scientists Prove Those Vaccinated for Shingles Can Infect Others with Chicken Pox

US National Library of Medicine
National Institutes of Health – Jun 2011

Study – Varicella Zoster Virus DNA at Inoculation Sites and in Saliva After Zostavax Immunization

Duane L. Pierson,1 Satish K. Mehta,2 Don Gilden,corresponding author4,5 Randall J. Cohrs,4 Maria A. Nagel,4 D. Scott Schmid,6 and Stephen K. Tyring3
1 Space Life Sciences, NASA, Lyndon B. Johnson Space Center
2 Enterprise Advisory Services, Inc
3 University of Texas Health Science Center, Houston, Texas
4 Department of Neurology
5 Microbiology, University of Colorado School of Medicine, Aurora
6 National VZV Laboratory, Centers for Disease Control and Prevention, Atlanta, Georgia

Correspondence: Don Gilden, MD, Department of Neurology, University of Colorado School of Medicine, 12700 E 19th Ave, Box B182, Aurora, CO 80045 (ude.revnedcu@nedlig.nod).

Abstract

Analysis of 36 individuals over age 60 years who were immunized with Zostavax revealed varicella zoster virus (VZV) DNA in swabs of skin inoculation sites obtained immediately after immunization in 18 (50%) of 36 subjects (copy number per nanogram of total DNA, 28 to 2.1 × 106) and in saliva collected over 28 days in 21 (58%) of 36 subjects (copy number, 20 to 248). Genotypic analysis of DNA extracted from 9 random saliva samples identified vaccine virus in all instances. In some immunized individuals over age 60, vaccine virus DNA is shed in saliva up to 4 weeks.
Varicella zoster virus (VZV) is a neurotropic alphaherpesvirus. Primary infection usually causes varicella (chicken pox) in children. Airborne VZV enters the nasopharynx and replicates in tonsillar T cells followed by viremia and skin lesions [1, 2]. After primary infection, VZV becomes latent in neurons of cranial nerve ganglia, dorsal root ganglia, and autonomic ganglia along the entire neuraxis. Decades later, VZV reactivates in elderly and immunocompromised individuals to produce zoster (shingles), a syndrome characterized by pain and a vesicular rash on an erythematous base in 1–3 dermatomes. Zoster is common, with ∼1,000,000 cases annually in the United States. Importantly, zoster is often followed by chronic pain (postherpetic neuralgia [PHN]) as well as by meningoencephalitis, cerebellitis, cranial nerve palsies, vasculopathy, myelopathy, and multiple inflammatory diseases of the eye [3].
To prevent zoster and its attendant neurological complications, Zostavax vaccine (Merck) was approved by the Food and Drug Administration for use in individuals at least 60 years of age. Over a 3-year period, Zostavax effectively reduced the risk of zoster by 51% and PHN by 66% in nearly 20,000 healthy adults age 60 years or older [4]. Zostavax contains live attenuated VZV, and the package insert warns newly vaccinated individuals to avoid contact for an unspecified time with newborn infants, immunosuppressed individuals, and pregnant women who have not had chicken pox or have not been immunized for chicken pox. Because VZV DNA is present in saliva of zoster patients for at least 2 weeks [5] and VZV in saliva can also be infectious [6], we examined the inoculation site and saliva of Zostavax-vaccinated subjects for the presence of VZV DNA for 4 weeks after immunization.

US National Library of Medicine
National Institutes of Health – 1980

Study – Contact vaccinia from recently vaccinated British soldiers

SIR,-The recommendations and medicolegal implications of smallpox vaccination have been discussed in these columns on several occasions
(11 October 1980, p 1004; 25 October, pp 1141 and 1142).
Although vaccination for the public is no longer necessary it is worth noting, as Minerva pointed out (4 April, p 1163), that it continues to be offered to the British Army (both regular and reserve). The risk of transmission of vaccinia by recently vaccinated soldiers to their close and immediate susceptible contacts therefore is likely to increase. This has been illustrated in the following case. A 23-year-old Scottish housewife was referred to the gynaecology department of this hospital on 17 December from the local family planning clinic for confirmation of diagnosis of presumed genital herpes simplex infection. The patient had developed painful itchy lesions on the vulva one week previously and she had also noticed similar lesions on her left loin and ear lobe. On examination she had large moist umbilicated vesicles on the vulva as well as on her left hip and left ear lobe. A clinical diagnosis of vaccinia was confirmed at the regional virus laboratory, Ruchill Hospital, by electron microscopy, and vaccinia virus was isolated in cell culture. These lesions rapidly regress,.d and healed with local application of betadine paint. The history of contact with a vaccinated person was not volunteered; but on close questioning it was revealed that the patient’s husband, who had joined the Royal Air Force, had been vaccinated three weeks previously and had been home at weekends. The patient herself had not been vaccinated in the past. In 1980, of six reported incidents of contact vaccinia received by the Communicable Disease Surveillance Centre,1 one was almost identical to our own case: a young woman whose soldier husband had been vaccinated three weeks previously developed genital vaccinia. Another case was in a soldier who had taken part in a boxing match and may have been infected by a colleague. The immediate and obvious question that arises is whether vaccination in the armed Forces is justifiable when there is no valid medical reason for it, and it is no longer necessary for international travel (except to Chad and democratic Kampuchea). The policy of smallpox vaccination has been discussed in a recent editorial of the Jrournal of the Royal Army Medical Corps2 and the main argument for vaccination seems to be to protect the Forces against the possible use of smallpox virus by an enemy as an agent of biological warfare. If the vaccination of the army personnel should continue because of this unlikely but perfectly feasible threat of germ warfare, one can only endorse the view that “Continued education of service personnel and their contacts about the risk and its prevention is now, therefore, even more essential than before.”3 Otherwise we might see more cases of genital vaccinia in women transmitted from recently vaccinated young, healthy, virile British soldiers.

US National Library of Medicine
National Institutes of Health – Feb 2012

Study – Contact transmission of vaccinia virus from smallpox vaccinees in the United States, 2003-2011.

Wertheimer ER, Olive DS, Brundage JF, Clark LL.
Author information
Armed Forces Health Surveillance Center, 11800 Tech Road, Suite 220, Silver Spring, MD 20904, USA. ellen.wertheimer@us.army.mil

Abstract
Since 2002, approximately 40,000 US civilians and 2.1 million military personnel have been vaccinated against smallpox. The vaccine contains live vaccinia virus that can be transferred through physical contact. This report summarizes numbers, rates, and characteristics of contact vaccinia cases that presented between December 2002 and March 2011. Cases were identified from reports in adverse event reporting systems and peer-reviewed literature. One hundred fifteen cases of vaccinia transmission through contact were identified (5.4 per 100,000 vaccinees); 52 reports (45%) noted laboratory confirmation. Three-quarters of vaccinees, but fewer than 8% of contact vaccinia cases, were described as military members. Most cases were household or intimate contacts (n=86, 75%) or wrestling partners (n=18, 16%) of vaccinees. Nearly all cases manifested mild, local skin reactions; of 14 hospitalized cases, one was life-threatening. Vaccinia transmission from vaccinees is relatively infrequent. Continued attention to both vaccinee education and screening for contraindications to vaccination is appropriate.

VAXXED TV – Lunchtime in Australia

Channel 7 news Australia

Fake News on The Radio!

MMR Gave my son autism

My son is vaccine injured

Vaccines injured me and my daughter

Q&A Brisbane, Australia

Sunshine Coast people’s study – Vaccinated vs. Unvaccinated

Q&A Maleny, Australia #vaxxed #PrayBig

What I Know Now

****************************************************

ONE FOR ISRAEL Ministry – Jewish Johnathan Ben-David forgave his killer and you would not believe why!!!

How to accept Jesus Christ as your personal Saviour

Testimony by Phil Robertson from Duck Dynasty

1 Corinthians 15 Authorized (King James) Version (AKJV)
1 Moreover, brethren, I declare unto you the gospel which I preached unto you, which also ye have received, and wherein ye stand;
2 by which also ye are saved, if ye keep in memory what I preached unto you, unless ye have believed in vain.
3 For I delivered unto you first of all that which I also received, how that Christ died for our sins according to the scriptures;
4 and that he was buried, and that he rose again the third day according to the scriptures:

Hebrews 6 Authorized (King James) Version (AKJV)
1 Therefore leaving the principles of the doctrine of Christ, let us go on unto perfection; not laying again the foundation of repentance from dead works, and of faith toward God,
2 of the doctrine of baptisms, and of laying on of hands, and of resurrection of the dead, and of eternal judgment.
3 And this will we do, if God permit.
4 For it is impossible for those who were once enlightened, and have tasted of the heavenly gift, and were made partakers of the Holy Ghost,
5 and have tasted the good word of God, and the powers of the world to come,
6 if they shall fall away, to renew them again unto repentance; seeing they crucify to themselves the Son of God afresh, and put him to an open shame.
7 For the earth which drinketh in the rain that cometh oft upon it, and bringeth forth herbs meet for them by whom it is dressed, receiveth blessing from God:
8 but that which beareth thorns and briers is rejected, and is nigh unto cursing; whose end is to be burned.

Isaiah 53 – Old testament Prophecy about Jesus

1 Who hath believed our report? and to whom is the arm of the Lord revealed?
2 For he shall grow up before him as a tender plant,and as a root out of a dry ground:he hath no form nor comeliness;and when we shall see him,there is no beauty that we should desire him.
3 He is despised and rejected of men;a man of sorrows, and acquainted with grief:and we hid as it were our faces from him;he was despised, and we esteemed him not.
4 Surely he hath borne our griefs,and carried our sorrows:yet we did esteem him stricken,smitten of God, and afflicted.
5 But he was wounded for our transgressions,he was bruised for our iniquities:the chastisement of our peace was upon him;and with his stripes we are healed.
6 All we like sheep have gone astray;we have turned every one to his own way;and the Lord hath laid on him the iniquity of us all.
7 He was oppressed, and he was afflicted,yet he opened not his mouth:he is brought as a lamb to the slaughter,and as a sheep before her shearers is dumb,so he openeth not his mouth.
8 He was taken from prison and from judgment:and who shall declare his generation? for he was cut off out of the land of the living:for the transgression of my people was he stricken.
9 And he made his grave with the wicked,and with the rich in his death;because he had done no violence,neither was any deceit in his mouth.
10 Yet it pleased the Lord to bruise him;he hath put him to grief:when thou shalt make his soul an offering for sin,he shall see his seed, he shall prolong his days,and the pleasure of the Lord shall prosper in his hand.
11 He shall see of the travail of his soul, and shall be satisfied:by his knowledge shall my righteous servant justify many;for he shall bear their iniquities.
12 Therefore will I divide him a portion with the great,and he shall divide the spoil with the strong;because he hath poured out his soul unto death:and he was numbered with the transgressors;and he bare the sin of many,and made intercession for the transgressors.

The Only Sin That Leads To Hell – Kenneth E Hagin

 

Vaccine News – VAXXED TV – I Wish We Would Have KNOWN! & Study – Failure to reach the goal of measles elimination. Apparent paradox of measles infections in immunized persons

US National Library of Medicine
National Institutes of Health – 22 Aug 1994

Study – Failure to reach the goal of measles elimination. Apparent paradox of measles infections in immunized persons.

Poland GA, Jacobson RM.
Author information
Department of Internal Medicine, Mayo Vaccine Research Group, Mayo Clinic and Foundation, Rochester, MN.

Abstract

BACKGROUND:
Measles is the most transmissible disease known to man. During the 1980s, the number of measles cases in the United States rose dramatically. Surprisingly, 20% to 40% of these cases occurred in persons who had been appropriately immunized against measles. In response, the United States adopted a two-dose universal measles immunization program. We critically examine the effect of vaccine failure in measles occurring in immunized persons.

METHODS:
We performed a computerized bibliographic literature search (National Library of Medicine) for all English-language articles dealing with measles outbreaks. We limited our search to reports of US and Canadian school-based outbreaks of measles, and we spoke with experts to get estimates of vaccine failure rates. In addition, we devised a hypothetical model of a school where measles immunization rates could be varied, vaccine failure rates could be calculated, and the percentage of measles cases occurring in immunized students could be determined.

RESULTS:
We found 18 reports of measles outbreaks in very highly immunized school populations where 71% to 99.8% of students were immunized against measles. Despite these high rates of immunization, 30% to 100% (mean, 77%) of all measles cases in these outbreaks occurred in previously immunized students. In our hypothetical school model, after more than 95% of schoolchildren are immunized against measles, the majority of measles cases occur in appropriately immunized children.

CONCLUSIONS:
The apparent paradox is that as measles immunization rates rise to high levels in a population, measles becomes a disease of immunized persons. Because of the failure rate of the vaccine and the unique transmissibility of the measles virus, the currently available measles vaccine, used in a single-dose strategy, is unlikely to completely eliminate measles. The long-term success of a two-dose strategy to eliminate measles remains to be determined.

Measles among vaccinated Quebec kids questioned
The Canadian Press Posted: Oct 20, 2011

An investigation into an outbreak in a high school in a town that was heavily hit by the virus found that about half of the cases were in teens who had received the recommended two doses of vaccine in childhood — in other words, teens whom authorities would have expected to have been protected from the measles virus.
It’s generally assumed that the measles vaccine, when given in a two-dose schedule in early childhood, should protect against measles infection about 99 per cent of the time. So the discovery that 52 of the 98 teens who caught measles were fully vaccinated came as a shock to the researchers who conducted the investigation.
“That’s the real question. How could that have happened?” said Dr. Gaston De Serres, an infectious diseases expert with Quebec’s public health agency and one of the authors of the study.
In an interview before the start of the conference, De Serres would not name the highly affected town or the high school in it.
But he suggested the discovery that as many of the cases were fully vaccinated as unvaccinated raises a serious question about whether the timing of the delivery of the first dose of measles vaccine is undermining the efficacy of the prevention program.

The vaccine can’t be given earlier, because of a phenomenon that helps babies survive infancy. Children are born without a fully developed immune system — it starts to build as babies become exposed to a variety of disease threats over their first few years.
In pregnancy and after birth, through breastfeeding, babies acquire antibodies from their mothers that tide them over until they can make their own. But that means if they are given the measles vaccine — which is made from weakened live viruses — too early, their mothers’ antibodies will kill the vaccine viruses, preventing protection from being induced.

US National Library of Medicine
National Institutes of Health – 2006

Study – Horizontal transmission of the Leningrad-3 live attenuated mumps vaccine virus

Abstract
Here we describe symptomatic transmission of the Leningrad-3 mumps vaccine virus from healthy vaccinees to previously vaccinated contacts. Throat swab and serum samples were taken from six symptomatic mumps cases and from 13 family contacts. Assessment of serum IgG and IgM anti-mumps virus antibodies and IgG avidity testing was performed using commercial test kits. Sera neutralizing antibodies were measured by plaque reduction neutralization assay using the L-3 vaccine mumps virus as the target. All six of the symptomatic mumps cases and three contact subjects tested positive for mumps by RT-PCR. The genomic sequences tested (F, SH and HN genes) of all nine of these samples were identical to the L-3 mumps vaccine strain. All 13 contacts were asymptomatic; however clear serological evidence of mumps infection was found in some of them. The likely epidemiological source of the transmitted L-3 mumps virus was children who were recently vaccinated at the schools attended by the six symptomatic mumps patients described here. The L-3 mumps vaccine virus can be shed and transmitted horizontally, even to subjects previously vaccinated with the same virus.

US National Library of Medicine
National Institutes of Health – 2014

Study – Difficulties in Eliminating Measles and Controlling Rubella and Mumps: A Cross-Sectional Study of a First Measles and Rubella Vaccination and a Second Measles, Mumps, and Rubella Vaccination

Zhifang Wang,1 Rui Yan,1 Hanqing He,1 Qian Li,1 Guohua Chen,2 Shengxu Yang,3 and Enfu Chen1,*
Martyn Kirk, Editor
1 – Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, Zhejiang Province, P. R. China
2 – Cixi City Center for Disease Control and Prevention, Cixi, Ningbo, P. R. China
3 – Sanmen County Center for Disease Control and Prevention, Sanmen, Taizhou, P. R. China

Abstract

Background
The reported coverage of the measles–rubella (MR) or measles–mumps–rubella (MMR) vaccine is greater than 99.0% in Zhejiang province. However, the incidence of measles, mumps, and rubella remains high. In this study, we assessed MMR seropositivity and disease distribution by age on the basis of the current vaccination program, wherein the first dose of MR is administered at 8 months and the second dose of MMR is administered at 18–24 months.

Methods
Cross-sectional serological surveys of MMR antibodies were conducted by collecting epidemiological data in Zhejiang province, China in 2011. In total, 1015 participants were randomly selected from two surveillance sites. Serum MMR-specific immunoglobulin G levels were tested by enzyme-linked immunosorbent assay. The geometric mean titers and seroprevalence with 95% confidence intervals (CIs) were calculated by age and gender. Proportions of different dose of vaccine by age by vaccine were also identified. Statistically significant differences between categories were assessed by the Chi-square test.

Results
Over 95% seroprevalence rates of measles were seen in all age groups except <7 months infants. Children aged 5–9 years were shown lower seropositivity rates of mumps while elder adolescences and young adults were presented lower rubella seroprevalence. Especially, rubella seropositivity was significantly lower in female adults than in male. Nine measles cases were unvaccinated or unknown vaccination history. Among them, 66.67% (6/9) patients were aged 20–29 years while 33.33% (3/9) were infants aged 8–12 months. In addition, 57.75% (648/1122) patients with mumps were children aged 5–9 years, and 50.54% (94/186) rubella cases were aged 15–39 years.

Conclusions
A timely two-dose MMR vaccination schedule is recommended, with the first dose at 8 months and the second dose at 18–24 months. An MR vaccination speed-up campaign may be necessary for elder adolescents and young adults, particularly young females.

I am injured by the flu shot

MMR vaccine injured me

My family is injured by vaccines

Hep B vaccine and Vit K made my baby sick

I Wish We Would Have KNOWN!
William and Rachael tell their story of their two boys who have suffered from vaccine injury in Ireland.
Interview recorded on May 5th, 2017 in The United Kingdom

I have finally woken up to the truth about vaccines

My 2 children have autism from vaccines

My son should never be vaccinated

Vaccines gave my son autism

My son caught measles from the MMR vaccine

****************************************************

How to accept Jesus Christ as your personal Saviour

Testimony by Phil Robertson from Duck Dynasty

1 Corinthians 15 Authorized (King James) Version (AKJV)
1 Moreover, brethren, I declare unto you the gospel which I preached unto you, which also ye have received, and wherein ye stand;
2 by which also ye are saved, if ye keep in memory what I preached unto you, unless ye have believed in vain.
3 For I delivered unto you first of all that which I also received, how that Christ died for our sins according to the scriptures;
4 and that he was buried, and that he rose again the third day according to the scriptures:

Hebrews 6 Authorized (King James) Version (AKJV)
1 Therefore leaving the principles of the doctrine of Christ, let us go on unto perfection; not laying again the foundation of repentance from dead works, and of faith toward God,
2 of the doctrine of baptisms, and of laying on of hands, and of resurrection of the dead, and of eternal judgment.
3 And this will we do, if God permit.
4 For it is impossible for those who were once enlightened, and have tasted of the heavenly gift, and were made partakers of the Holy Ghost,
5 and have tasted the good word of God, and the powers of the world to come,
6 if they shall fall away, to renew them again unto repentance; seeing they crucify to themselves the Son of God afresh, and put him to an open shame.
7 For the earth which drinketh in the rain that cometh oft upon it, and bringeth forth herbs meet for them by whom it is dressed, receiveth blessing from God:
8 but that which beareth thorns and briers is rejected, and is nigh unto cursing; whose end is to be burned.

 

Vaccine News – Study – Metals Debris Found in Vaccine Supply

Lead developer of HPV vaccine admits it’s a giant, deadly scam
Thursday, September 29, 2016 by: Samantha Debbie
(NaturalNews) An expert involved in the approval process for the human papilloma virus (HPV) vaccines Gardasil and Cervarix, is speaking out about the dangers and why you shouldn’t risk your child’s health in getting them.
Diane Harper, M.D., professor and chair of the department of Family and Geriatric Medicine at the University of Louisville, revealed at the 4th International Conference on Vaccination that HPV vaccines are essentially worthless, because rates of cervical cancer in the U.S. are extremely low anyway.
Her speech was intended to promote the benefits of vaccines, but she changed her mind and went in a different direction in an effort to “clean her conscience about the deadly vaccines,” according to The Daily Sheeple.
Dr. Harper, a former vaccine research scientist for Merck, said she wouldn’t be able to sleep at night unless she aired the truth about HPV vaccines. In her speech, given in Reston, Virginia, she said that 70 percent of all HPV infections resolve themselves without treatment, and 90 percent do so within two years.
Over 40 young girls reported to have died from HPV vaccines
All safety trials for HPV vaccines were done on 15-year-olds, said Dr. Harper, and not 9-year-olds, the demographic for which the immunizations are now recommended. Furthermore, there is a real risk associated with these vaccines, she added.
More than 15,000 girls have experienced adverse side effects from Gardasil, according to the Vaccine Adverse Event Reporting System (VAERS). A number likely to be far higher in reality, since many vaccine side effects go unreported.
At least 44 girls are known to have died from these vaccines. Some side effects experienced by those receiving the HPV vaccines include seizures, blood clots, brain inflammation, lupus and Guillain Barre Syndrome, a rare but serious autoimmune deficiency that causes the immune system to attack and damage nerve cells.
While the majority of those with GBS recover, the disorder may cause muscle weakness, difficulty breathing, paralysis and sometimes death.
As with most vaccines, parents are usually not made aware of the risks.
HPV vaccines work on only four of the 40 strains of the venereal disease

How Vaccinated Kids Infect The Non-Vaccinated
Posted on:Sunday, February 8th 2015 at 3:45 pm Written By: Sayer Ji, Founder
This article is copyrighted by GreenMedInfo LLC, 2015
With the thousands of mainstream media articles blaming the non-vaccinated for disease outbreaks, this article will provide a necessary counterbalance by showing the vaccinated can (and do) infect the non-vaccinated…
A groundbreaking study published in 2013 in the journal Vaccine titled, “Comparison of virus shedding after lived attenuated and pentavalent reassortant rotavirus vaccine,” referenced the fact that rotavirus vaccines contain live viruses capable of causing infection, shedding and even transmission to non-vaccinated subjects:
“In fact, transmission of these two rotavirus vaccines or vaccine-reassortment strains to unvaccinated contacts has been detected [9–13][1], even in the absence of symptoms.”
One of the five studies referenced in the passage above confirming that the vaccinated can infect the non-vaccinated, “Sibling transmission of vaccine-derived rotavirus (RotaTeq) associated with rotavirus gastroenteritis,” published in 2009, is the first report in the literature to identify the transmission of rotavirus vaccine-derived virus to unvaccinated contacts resulting in symptomatic rotavirus gastroenteritis requiring emergency medical attention:
“We document here the occurrence of vaccine-derived rotavirus (RotaTeq [Merck and Co, Whitehouse Station, NJ]) transmission from a vaccinated infant to an older, unvaccinated sibling, resulting in symptomatic rotavirus gastroenteritis that required emergency department care.”
The study also indicated that two of the five strains of rotavirus within the Rotateq reassorted to produce a more harmful virus either within the vaccinated infant or within the subsequently infected unvaccinated sibling:
“Results of our investigation suggest that reassortment between vaccine component strains of genotypes P7[5]G1 and P1A[8]G6 occurred during replication either in the vaccinated infant or in the older sibling, raising the possibility that this reassortment may have increased the virulence of the vaccine-derived virus.”
This phenomenon of Rotateq vaccine strain reassortment and subsequent gastoenteritis infection in vaccine recipients was also observed in a 2012 study in 61 infants.[2] Additionally, A Nicaraguan study published in 2012 found “the widespread use of the RotaTeq vaccine has led to the introduction of vaccine genes into circulating human RVs.,” revealing that the widespread introduction of the vaccine strain has altered the genetic makeup of wild-type rotavirus that now infects exposed populations.[3]
It has been estimated that between 80-100% of infants shed rotavirus at some point during 25-28 days after vaccination.[4] [5] This reveals that the vaccinated, contrary to widespread assumptions about the the risks represented by the non-vaccinated, pose a clear risk of infecting the non-vaccinated, and may be producing the ideal virological conditions for the recombination of diverse rotavirus strains into vaccine-resistant ‘super viruses.’
Another case study, reported on in the National Vaccine Information Center’s document on vaccine viral shedding:
“In 2010, a case report was published in Pediatrics describing a 30-month old healthy boy who had never received rotavirus vaccine and was infected with vaccine strain rotavirus. 237 He ended up in the emergency room with severe gastroenteritis 10 days after his healthy two-month old brother was given a dose of Merck’s RotaTeq vaccine. A stool sample was taken in the emergency room and came back positive for RotaTeq vaccine derived strains after RT-PCR testing.”
The authors of the case report noted that “transmission of RotaTeq strains to unvaccinated contacts was not evaluated in the pivotal [pre-licensure] clinical trials.” They added that  both RotaTeq and Rotarix [GlaxoSmithKline Biologicals] vaccines have “the potential for vaccine-virus transmission to contacts.”

Study 2014 Feb 26 – Comparison of virus shedding after lived attenuated and pentavalent reassortant rotavirus vaccine.
Transmission of rotavirus vaccine or vaccine-reassortant strains to unvaccinated contacts has been reported. Therefore, it is essential to evaluate and characterize the nature of vaccine-virus shedding among rotavirus vaccine recipients. Two groups of healthy infants who received a complete course of RotaTeq (RV5) or Rotarix (RV2) were enrolled (between March 2010 and June 2011) to compare fecal shedding for one month after each vaccine dose. Shedding was assessed using both enzyme immunoassay (EIA) and real-time reverse transcription-polymerase chain reaction (RT-PCR). Eighty-seven infants (34 girls and 53 boys) were enrolled in the study. After the first vaccine dose, the peak time of virus shedding occurred between day 4 and day 7, with positive detection rates of 80-90% by real-time RT-PCR and 20-30% by EIA. In both groups, vaccine shedding occurred as early as one day and as late as 25-28 days. Mixed effects logistic regression analysis of real-time RT-PCR data showed no significant differences between two groups when shedding rates were compared after the first vaccine dose (odds ratio [OR] 1.26; P=0.71) or after the second vaccine dose (odds ratio [OR] 1.26; P=0.99). However, infants receiving RV2 shed significantly higher viral loads than those receiving RV5 when compared after the first vaccine dose (P=0.001) and after the second dose (P=0.039). In terms of shedding rates detected by real-time RT-PCR, vaccine uptake of RV5 or RV2 among infants in Taiwan was comparable. Clinical significance of higher shedding viral loads in RV2 should be further observed.

Study 2010 Feb – Sibling transmission of vaccine-derived rotavirus (RotaTeq) associated with rotavirus gastroenteritis.
Although rotavirus vaccines are known to be shed in stools, transmission of vaccine-derived virus to unvaccinated contacts resulting in symptomatic rotavirus gastroenteritis has not been reported to our knowledge. We document here the occurrence of vaccine-derived rotavirus (RotaTeq [Merck and Co, Whitehouse Station, NJ]) transmission from a vaccinated infant to an older, unvaccinated sibling, resulting in symptomatic rotavirus gastroenteritis that required emergency department care. Results of our investigation suggest that reassortment between vaccine component strains of genotypes P7[5]G1 and P1A[8]G6 occurred during replication either in the vaccinated infant or in the older sibling, raising the possibility that this reassortment may have increased the virulence of the vaccine-derived virus. Both children remain healthy 11 months after this event and are without underlying medical conditions.

CDC – The Emerging Risks of Live Virus & Virus Vectored Vaccines: Vaccine Strain Virus Infection, Shedding & Transmission
Referenced Report from the National Vaccine Information Center
by Barbara Loe Fisher Co-founder & President
Your Health. Your Family. Your Choice.
Can People Receiving Live Virus Vaccines Transmit Vaccine Strain Virus to Others?
Public health officials say that unvaccinated children pose a big danger to those around them and even threaten the health of fully vaccinated children and adults because vaccines can fail to prevent infection in vaccinated persons.
Today, the most common argument used to justify “no exceptions” mandatory vaccination laws is that unvaccinated people pose a serious health threat to others who “cannot be vaccinated,” such as the immunocompromised.
Some parents of unvaccinated children are asking the opposite question:
Could my unvaccinated or immune compromised child get sick from coming in contact with a recently vaccinated person?
When it comes to live virus vaccines, the short answer is:
Yes.
During a viral infection, live virus is shed in the body fluids of those who are infected for varying amounts of time and can be transmitted to others. Vaccine strain live virus is also shed for varying amounts of time in the body fluids of vaccinated people and can be transmitted to others. Although public health officials maintain that live attenuated virus vaccines rarely cause complications in the vaccinated person and that vaccine strain viral shedding rarely causes disease in close contacts of the recently vaccinated, it is important to be aware that vaccine strain live virus infection can sometimes cause serious complications in vaccinated persons and vaccine strain live viruses can be shed and transmitted to others with serious or even fatal consequences

Censored Study of Vaccinated vs. Unvaccinated sees Daylight
by James O. Grundvig
The study defined NDD as “Autism Spectrum Disorder, Attention Deficit Hyperactivity Disorder, and/or a learning disability.”
The Study Accepted, Released, Censored
Frontiers Journal received the study on September 17, 2016. After a two-month peer review process, published it on November 21 for its “68,000 on board editors” from institutions around the world (www.frontiersin.org), with the National Institute of Health (NIH) and Harvard University being the top two providing the science editors.
Over the course of four days, more than 80,000 views of the study found it important enough to read, going “viral” according to one familiar with its release. Then on November 28, the bottom fell out when Frontiers scrapped the publication. In one week, it went from being accepted, published, and then retracted. The abstract can still be found online.
The paper, however, wasn’t retracted; it was “unaccepted,” according to Mawson via email. That means Frontiers didn’t retract it, since it was never officially published. What’s left for a study after its accepted, reviewed 80,000 times in less than 100 hours? . . . Censorship.
Beyond that clarification, Mawson wrote: “I am not allowed to comment on the paper/work by my Dean.”
Melissa Cochrane, the communications manager for Frontiers Journal, which is headquartered in Lausanne, Switzerland, replied via email:
“As we have previously noted, this article was provisionally accepted but not published. In response to concerns raised regarding the abstract and the provisional PDF — which were made provisionally available online — Frontiers then reopened its review. Following further manuscript assessment by the Field Chief Editor of Frontiers in Public Health, in consultation with an external expert, the manuscript was subsequently rejected, not retracted as retraction can only occur once a paper has been officially published and indexed.
“The rejection was due to severe limitations in the validity of the results.”
A day later, Ms. Cochrane replied to an email seeking clarification on the “rejection” process, writing:
“The reasons for the rejection were communicated in more detail to the corresponding author but I am unable to give you the reviewer’s comments as the Frontiers’ review process involves an open and collaborative dialogue between the reviewers and the authors, all of whom participate with the understanding and security that Frontiers will keep these exchanges confidential, as explained in our terms of use. You can read more about the Frontiers peer review process here.”
Vaccines Cause Health Issues Big and Small

Metals Debris Found in Vaccine Supply
Robert F. Kennedy, Jr.
A landmark new study has found metal debris and biological contamination in every human vaccine tested. The study should have profound and immediate impact on public health policies and vaccine industry procedures around the globe.
A team of scientists used a highly sensitive technology—an Environmental Scanning Electron Microscope equipped with an x-ray microprobe—to scan for solid contaminants in 44 samples of 30 vaccines. The researchers reported their results in the International Journal of Vaccines and Vaccination. They found widespread contamination by toxic aluminum salts, red blood cells of unknown origin and inorganic, foreign particle debris in aggregates, clusters and independent particulates. The composition of those clusters, the researchers observe, are consistent with “burnt waste.”

Study – New Quality-Control Investigations on Vaccines: Micro-and Nanocontamination
International Journal of Vaccines and Vaccination
Abstract
Vaccines  are  being  under  investigation  for  the  possible  side  effects  they  can cause. In order to supply new information, an electron-microscopy investigation method was applied to the study of vaccines, aimed at verifying the presence of solid contaminants by means of an Environmental Scanning Electron Microscope equipped  with  an  X-ray  microprobe.  The  results  of  this  new  investigation  show the presence of micro- and nanosized particulate matter composed of inorganic elements in vaccines’ samples which is not declared among the components and whose unduly presence is, for the time being, inexplicable. A considerable part of  those  particulate  contaminants  have  already  been  verified  in  other  matrices and  reported  in  literature  as  non  biodegradable  and  non  biocompatible.  The evidence  collected  is  suggestive  of  some  hypotheses  correlated  to  diseases  that are mentioned and briefly discussed.

Vaccine News – Dr. Suzanne Humphries, M.D. – Vaccine Strain of Measles Virus Found in Measles

Dirty Vaccines: Every Human Vaccine Tested Was Contaminated With Metals and Debris in New Study
Researchers examining 44 samples of 30 different vaccines found dangerous contaminants, including red blood cells in one vaccine and metal toxicants in every single sample tested – except in one animal vaccine.
Using extremely sensitive new technologies not used in vaccine manufacturing, Italian scientists reported they were “baffled” by their discoveries which included single particles and aggregates of organic debris including red cells of human or possibly animal origin and metals including lead, tungsten, gold, and chromium, that have been linked to autoimmune disease and leukemia.
In the study, published this week in the International Journal of Vaccines and Vaccination, the researchers led by Antoinetta Gatti, of the National Council of Research of Italy and the Scientific Director of Nanodiagnostics, say their results “show the presence of micro- and nano-sized particulate matter composed of inorganic elements in vaccine samples” not declared in the products’ ingredients lists.
Lead particles were found in the cervical cancer vaccines, Gardasil and Cevarix, for example, and in the seasonal flu vaccine Aggripal manufactured by Novartis as well as in the Meningetec vaccine meant to protect against meningitis C.
Samples of an infant vaccine called Infarix Hexa (against diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis and haemophilus influenzae type B) manufactured by GlaxoSmithKline was found to contain stainless steel, tungsten and a gold-zinc aggregate.
Other metal contaminants included platinum, silver, bismuth, iron, and chromium. Chromium (alone or in alloy with iron and nickel) was identified in 25 of the human vaccines from Italy and France that were tested.
GSK’s Fluarix vaccine for children three years and older contained 11 metals and aggregates of metals. Similar aggregates to those identified in the vaccines have been shown to be prevalent in cases of leukemia, the researchers noted.
Many of the vaccines contained iron and iron alloys which, according to the researchers, “can corrode and the corrosion products exert a toxicity affecting the tissues”.
The researchers supply an image of an area in a drop of Sanofi Pasteur MSD’s Repevax (diphtheria, pertussis, tetanus, polio) vaccine “where the morphology of red cells – we cannot tell whether they are human or animal- is clearly visible” along with the presence of “debris” composed of aluminum, bromine, silicon, potassium and titanium.
Feligen, the only veterinary vaccine tested in the 44 total vaccines sampled, proved to be the only sample free from inorganic contamination.

Dirty Vaccines: New Study Reveals Prevalence of Contaminants
Posted by Celeste McGovern on Jan 30, 2017 5:31:20 PM
Every Human Vaccine Tested Was Contaminated by Unsafe Levels of Metals and Debris Linked to Cancer and Autoimmune Disease, New Study Reports
Researchers examining 44 samples of 30 different vaccines found dangerous contaminants, including red blood cells in one vaccine and metal toxicants in every single sample tested – except in one animal vaccine.
Using extremely sensitive new technologies not used in vaccine manufacturing, Italian scientists reported they were “baffled” by their discoveries which included single particles and aggregates of organic debris including red cells of human or possibly animal origin and metals including lead, tungsten, gold, and chromium, that have been linked to autoimmune disease and leukemia.
In the study, published this week in the International Journal of Vaccines and Vaccination, the researchers led by Antonietta Gatti, of the National Council of Research of Italy and the Scientific Director of Nanodiagnostics, say their results “show the presence of micro- and nano-sized particulate matter composed of inorganic elements in vaccine samples” not declared in the products’ ingredients lists.
Lead particles were found in the cervical cancer vaccines, Gardasil and Cervarix, for example, and in the seasonal flu vaccine Aggripal manufactured by Novartis as well as in the Meningetec vaccine meant to protect against meningitis C.
Samples of an infant vaccine called Infarix Hexa (against diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis and haemophilus influenzae type B) manufactured by GlaxoSmithKline was found to contain stainless steel, tungsten and a gold-zinc aggregate.

PDF source: http://medcraveonline.com/IJVV/IJVV-04-00072.pdf
Study – New Quality-Control Investigations on Vaccines: Micro-and Nanocontamination
International Journal of Vaccines and Vaccination
Abstract
Vaccines  are  being  under  investigation  for  the  possible  side  effects  they  can cause. In order to supply new information, an electron-microscopy investigation method was applied to the study of vaccines, aimed at verifying the presence of solid contaminants by means of an Environmental Scanning Electron Microscope equipped  with  an  X-ray  microprobe.  The  results  of  this  new  investigation  show the presence of micro- and nanosized particulate matter composed of inorganic elements in vaccines’ samples which is not declared among the components and whose unduly presence is, for the time being, inexplicable. A considerable part of  those  particulate  contaminants  have  already  been  verified  in  other  matrices and  reported  in  literature  as  non  biodegradable  and  non  biocompatible.  The evidence  collected  is  suggestive  of  some  hypotheses  correlated  to  diseases  that are mentioned and briefly discussed.

Parents of children with autistic spectrum disorder report extreme fatigue
Pamela Cowan, Regina Leader-Post
Published on: January 13, 2017
For more than two years, Sarah Elizabeth Ivens was fascinated to work one-on-one with children who have autism spectrum disorder.
“It’s amazing how the mind can work differently,” she said.
As she got to know the childrens’ families, Ivens was struck by the many challenges they juggled and their high level of fatigue.
“Fatigue is a sense of exhaustion that cannot be resolved by getting rest,” she said. “It’s not just being tired. If you’re tired, then you can go to bed early, sleep in and the next day you’re feeling better. That’s not the case with fatigue.”
Fatigue impacts a person’s physical and mental capacities.
Ivens completed her honours degree in psychology at the University of Victoria, and is now a PhD student in clinical psychology at the University of Regina.
Her Victoria experience spurred her to take a closer look at parents’ experiences for her master’s thesis, titled Fatigue in parents of children with Autism Spectrum Disorders: The role of parental and child factors for mothers and fathers.
“We do know from other research that fatigue is problematic for parents in general and that it can really have a big impact on their well-being and their child rearing, which results in less-effective parenting,” Ivens said.
Past research focused on mothers. For her thesis, Ivens surveyed 112 parents of children with autism between the ages of two and 12 years, with the average age being seven.
“The kids had been diagnosed three years prior, so this was not families going through the transition of learning to deal with the diagnosis,” Ivens said. “These were parents who were doing it for a few years.”
Of those answering the online questionnaires for her 2015 study, 78 were mothers and 34 were fathers.
Getting dads involved was important. In many studies, only 10 per cent are fathers, she said.
“I think their answers and experiences are really getting lost in the noise,” Ivens said.
According to existing literature, mothers report being more fatigued than fathers, the 31-year-old said.
Her survey echoed that finding.

Merck Created Hit List to “Destroy,” “Neutralize” or “Discredit” Dissenting Doctors
By Jim Edwards May 6, 2009
Merck made a “hit list” of doctors who criticized Vioxx, according to testimony in a Vioxx class action case in Australia. The list, emailed between Merck employees, contained doctors’ names with the labels “neutralise,” “neutralised” or “discredit” next to them.
According to The Australian, Merck emails from 1999 showed company execs complaining about doctors who disliked using Vioxx. One email said:
We may need to seek them out and destroy them where they live …
The plaintiffs’ lawyer gave this assessment:
It gives you the dark side of the use of key opinion leaders and thought leaders … if (they) say things you don’t like to hear, you have to neutralise them … It does suggest a certain culture within the organisation about how to deal with your opponents and those who disagree with you.
The Australian:
The court was told that James Fries, professor of medicine at Stanford University, wrote to the then Merck head Ray Gilmartin in October 2000 to complain about the treatment of some of his researchers who had criticised the drug.
“Even worse were allegations of Merck damage control by intimidation,” he wrote, … “This has happened to at least eight (clinical) investigators … I suppose I was mildly threatened myself but I never have spoken or written on these issues.”
The allegations come on the heels of revelations that Merck created a fake medical journal — the Australasian Journal of Bone and Joint Medicine — in which to publish studies about Vioxx; had pop songs commissioned about Vioxx to inspire its staff, and paid ghostwriters to draft articles about the drug.

New Merck Allegations: A Fake Journal; Ghostwritten Studies; Vioxx Pop Songs; PR Execs Harass Reporters
By Jim Edwards April 23, 2009
Federal prosecutors in the U.S. will be reading with amusement the Australian press’s coverage of a class action trial down under for patients who took Merck’s now-withdrawn painkiller Vioxx.
Details emerging in Oz make some of the antics that Merck’s American counterparts got up to look tame by comparison. For example, in Australia, Merck allegedly:
Had a doctor sign his name to an entirely ghostwritten journal article even though a Merck staffer had complained that the data within it was based on “wishful thinking.”
Created a fake “peer-reviewed” journal, the “Australasian Journal of Bone and Joint Medicine,” in which to publicize pro-Vioxx articles.
Created a Ricky Martin-style pop song to get Merck sales reps all jazzed up about Vioxx (lyrics below!).
During the trial, Merck has employed an unusually aggressive set of PR consultants, some of whom have even followed reporters into the bathroom to make sure they got the story “right.”
Hatched a Blackadder-style “cunning plan” to seed seminars with speakers who were sympathetic to Vioxx but under instructions not to mention the brand name too often.
Regarding the “wishful thinking” study, The Age reports on these emails turned over in the trial:
Email from Merck senior researcher Briggs Morrison, August 2001:
“That seems wishful thinking, not a critical interpretation of the data … The data appears to have been interpreted to support a preconceived hypothesis.”
The claim was nonetheless included in the final version of the article, which Merck employees sent to US cardiologist Dr Marv Konstam for approval.
Dr Konstam was named as the article’s lead author when it was published in the medical journal Circulation in October 2001
The Australian describes the fake journal. And The Age notes that the journal was “designed to resemble a peer-reviewed publication and reprinted previously published articles.”

Merck target of Vioxx federal grand jury probe
Mon Mar 23, 2009
Merck & Co said on Monday that it has been advised it is a target of a U.S. grand jury investigation involving its withdrawn pain drug Vioxx.
The company had previously disclosed the government probe, which has been ongoing since 2004. But it only last week received a letter from the U.S. Attorney’s office for the District of Massachusetts informing the drugmaker it is a target of the grand jury investigation, Merck said.
The probe involves Merck’s research, marketing and selling activities regarding Vioxx, the once $2.5 billion a year drug that was pulled from the market in September 2004 after a study showed it doubled the risk of heart attack and stroke in long-term users.
Merck said it has responded and will continue to respond to requests from the U.S. Attorney for documents and information in connection with the probe. The investigation includes subpoenas for witnesses to appear before a grand jury, the company has said in securities filings.
The New Jersey-based drugmaker was sued by tens of thousands of former Vioxx users who claimed to have been injured by the arthritis medicine.
After winning the majority of product liability trials that reached a jury, Merck agreed to pay $4.85 billion to settle personal injury claims from former users who had suffered heart attacks and strokes.

Study – Investigating Viruses in Cells Used to Make Vaccines; and Evaluating the Potential Threat Posed by Transmission of Viruses to Humans
Principal Investigator: Arifa S. Khan, PhD
General Overview
The emergence of pathogenic virus infections like influenza and HIV have created an urgent need for new vaccines.
Virus-based vaccines are made in living cells (cell substrates). Some manufacturers are investigating the use of new cell lines to make vaccines. The continual growth of cell lines ensures that there is a consistent supply of the same cells that can yield high quantities of the vaccine.
In some cases the cell lines that are used might be tumorigenic, that is, they form tumors when injected into rodents. Some of these tumor-forming cell lines may contain cancer-causing viruses that are not actively reproducing. Such viruses are hard to detect using standard methods. These latent, or “quiet,” viruses pose a potential threat, since they might become active under vaccine manufacturing conditions. Therefore, to ensure the safety of vaccines, our laboratory is investigating ways to activate latent viruses in cell lines and to detect the activated viruses, as well as other unknown viruses, using new technologies. We will then adapt our findings to detect viruses in the same types of cell substrates that are used to produce vaccines. We are also trying to identify specific biological processes that reflect virus activity.
These methods will enable FDA scientists to help manufacturers to determine whether their specific cell substrate is safe to use for vaccine production. The methods our laboratory are developing and testing will help to ensure the production of safe and effective vaccines in two ways: 1) FDA will be able to develop testing guidelines for manufacturers who use new cell substrates for producing vaccines; and 2) FDA will publish the new methods it develops in peer-reviewed scientific journals, thus making them readily accessible to all manufacturers.
We are also evaluating the risk of retrovirus infections in humans. (Retroviruses are RNA viruses that use an enzyme called reverse transcriptase (RT) to replicate; RNA is the de-coded form of DNA). Simian foamy virus (SFV) can be transmitted from nonhuman primates (e.g., monkeys) to humans. Although there is no evidence that SFV causes disease, the virus can remain in a lifelong quiet state in the DNA after infection. Moreover, two individuals in Africa were recently found to be infected with both HIV-1 and SFV. Therefore, it is important to determine if SFV poses a threat to human health and to understand how the virus spreads in order to create strategies for controlling human infections. Such work will also help FDA to develop a new policy regarding blood donation by individuals working with nonhuman primates and implementing formal safety guidelines for people working with SFV-infected animals. We are also investigating the consequences of dual SFV and HIV-1 infection in the monkey model.

#RFKcommission – Great video! Dartmouth-educated and Portland, OR-based Pediatrician Dr. Paul Thomas responds to Dr. Peter Hotez’s ridiculous Op-Ed in the NY Times trying to talk President Trump out of having a Vaccine Safety Commission. Oregon proud!

Dr. Suzanne Humphries, M.D. – Vaccine Strain of Measles Virus Found in Measles Outbreaks
February 21, 2017
Health Impact News Editor Comments
Dr. Suzanne Humphries is a practicing nephrologist (kidney physician). In this lecture (video below), she addresses a study done in Croatia [1] where a child who was vaccinated with the MMR vaccine was tested positive for the measles vaccine strain Schwarz eight days after vaccination.
This was a significant finding, because the child’s symptoms were thought to be similar to rubella, and without testing, the sickness would have been possibly mis-diagnosed as rubella, or the wild-type strain of measles the vaccine is designed to protect against.
This concept of “shedding,” where the child comes down with the disease from the virus in the vaccine itself, surprised the researchers:
Virus excretion in vaccinees has been reported before, but to our knowledge, this is documented for the first time for the Schwarz vaccine strain. [1]
Since 2010, this phenomena of vaccine shedding with measles in the MMR vaccine has been observed in at least two other studies:
Differentiating the wild from the attenuated during a measles outbreak. Paediatrcis and Child Health, 2012:
In the midst of a local measles outbreak, a recently immunized child was investigated for a new-onset measles-type rash. Nucleic acid testing identified that a vaccine-type measles virus was being shed in the urine. Clinically differentiating measles from a nonmeasles rash is challenging, but can be supported by a thorough medical history evaluation. Rashes are expected to occur after immunization; nucleic acid testing can be used when it is difficult to differentiate between wild and attenuated strains. [2]
Case of vaccine-associated measles five weeks post-immunisation, British Columbia, Canada, Eurosurveillance, 2013:
We describe a case of vaccine-associated measles in a two-year-old patient from British Columbia, Canada, in October 2013, who received her first dose of measles-containing vaccine 37 days prior to onset of prodromal symptoms. Identification of this delayed vaccine-associated case occurred in the context of an outbreak investigation of a measles cluster. [3]
Are health officials testing cases of measles in the current outbreak in the United States, to determine if the measles strain is the wild strain of the vaccine strain?
Not likely, and it is not likely that the mainstream media “TV doctors” will even discuss this as they falsely vilify parents who choose not to administer the MMR vaccine to their children as the cause of these outbreaks. Some of these cases are confirmed to be among those who have received the MMR vaccine, and for those who have not been vaccinated, is it possible they were infected from those recently vaccinated when the vaccine was still “shedding,” and that the vaccine-strain of measles was passed on from the vaccinated child to the unvaccinated child?

Investigating Viruses in Cells Used to Make Vaccines; and Evaluating the Potential Threat Posed by Transmission of Viruses to Humans

Investigating Viruses in Cells Used to Make Vaccines; and Evaluating the Potential Threat Posed by Transmission of Viruses to Humans
In some cases the cell lines that are used might be tumorigenic, that is, they form tumors when injected into rodents. Some of these tumor-forming cell lines may contain cancer-causing viruses that are not actively reproducing. Such viruses are hard to detect using standard methods. These latent, or “quiet,” viruses pose a potential threat, since they might become active under vaccine manufacturing conditions. Therefore, to ensure the safety of vaccines, our laboratory is investigating ways to activate latent viruses in cell lines and to detect the activated viruses, as well as other unknown viruses, using new technologies. We will then adapt our findings to detect viruses in the same types of cell substrates that are used to produce vaccines. We are also trying to identify specific biological processes that reflect virus activity.
The use of tumorigenic and tumor-derived cells is a major safety concern due to the potential presence of viruses such as retroviruses and oncogenic DNA viruses that could be associated with tumorigencity, Therefore, detection of persistent, latent DNA viruses, and endogenous retroviruses in vaccine cell substrates is important for vaccine safety, particularly in the development of live viral vaccines, where there are no or minimal virus inactivation and removal steps during vaccine manufacturing.

Whooping cough resurgence due to vaccinated people not knowing they’re infectious?

Whooping cough resurgence due to vaccinated people not knowing they’re infectious?
Date:
June 24, 2015
Source:
Santa Fe Institute
Summary:
The dramatic resurgence of whooping cough is due, in large part, to vaccinated people who are infectious but who do not display the symptoms, suggests a new study.
…vaccinated people who are infectious but who do not display the symptoms of whooping cough, suggesting that the number of people transmitting without symptoms may be many times greater than those transmitting with symptoms.
The problem is, the newer vaccines might not block transmission. A January 2014 study in PNAS by another research team demonstrated that giving baboons acellular pertussis vaccines prevented them from developing symptoms of whooping cough but failed to stop transmission.
Building on that result, Althouse and Scarpino used whopping cough case counts from the CDC, genomic data on the pertussis bacteria, and a detailed epidemiological model of whooping cough transmission to conclude that acellular vaccines may well have contributed to — even exacerbated — the recent pertussis outbreak by allowing infected individuals without symptoms to unknowingly spread pertussis multiple times in their lifetimes.

Public Health Officials Know: Recently Vaccinated Individuals Spread Disease

Washington, D.C., March 3, 2015 (GLOBE NEWSWIRE) — Physicians and public health officials know that recently vaccinated individuals can spread disease and that contact with the immunocompromised can be especially dangerous. For example, the Johns Hopkins Patient Guide warns the immunocompromised to “Avoid contact with children who are recently vaccinated,” and to “Tell friends and family who are sick, or have recently had a live vaccine (such as chicken pox, measles, rubella, intranasal influenza, polio or smallpox) not to visit.”1
A statement on the website of St. Jude’s Hospital warns parents not to allow people to visit children undergoing cancer treatment if they have received oral polio or smallpox vaccines within four weeks, have received the nasal flu vaccine within one week, or have rashes after receiving the chickenpox vaccine or MMR (measles, mumps, rubella) vaccine.2
“The public health community is blaming unvaccinated children for the outbreak of measles at Disneyland, but the illnesses could just as easily have occurred due to contact with a recently vaccinated individual,” says Sally Fallon Morell, president of the Weston A. Price Foundation. The Foundation promotes a healthy diet, non-toxic lifestyle and freedom of medical choice for parents and their children. “Evidence indicates that recently vaccinated individuals should be quarantined in order to protect the public.”
Scientific evidence demonstrates that individuals vaccinated with live virus vaccines such as MMR (measles, mumps and rubella), rotavirus, chicken pox, shingles and influenza can shed the virus for many weeks or months afterwards and infect the vaccinated and unvaccinated alike.

Officials at the U.S. Centers for Disease Control and Prevention (CDC) say the best way to prevent pertussis is to get vaccinated. But data from the Vermont Department of Health (DOH) suggest that going through the pertussis vaccination regimen is not a sure-fire way to ward off the highly contagious disease.

In 2014, an outbreak of whooping cough (pertussis) broke out in the San Diego area. Of the 621 individuals who were infected, nearly all of them were completely up to date on all preventive vaccinations. If vaccines are given to protect from disease, how could this happen?
San Diego public health official Dr. Wilma Wooten argued that the cause was related to a decrease in the protection offered by vaccines after the first year. This answer is most revealing, in that it speaks to the actual efficacy of vaccines. It also shows that the concept of herd immunity is largely myth—and completely misunderstood.
The theory of herd immunity states that when a critical mass of the population (usually stipulated at 95%) is vaccinated against a disease, the possibility of outbreaks is eliminated. This is the main argument that is used to shame parents who wish to refuse certain vaccinations for their children: by not vaccinating, they put the health of the “herd” at risk.
However, if vaccines start losing effectiveness after the first year, as Dr. Wooten says, then constant revaccination would be required, since the immunity offered is only temporary for most vaccines. Achieving the required rate of protection is virtually impossible under this paradigm.
Of course, if we look back over the decades and note the lack of rampant epidemics in our nation, while remembering that vaccine protection is in perpetual decline, the myth of herd immunity quickly unravels. Our society has never achieved this level of herd immunity, yet not a single major outbreak of disease has occurred.
The argument for herd immunity was actually developed out of observations of natural immunity, not vaccination. Statisticians observed that populations were protected when sufficient members contracted the wild form of a disease, and subsequently acquired lifelong immunity. With vaccines, however, evidence shows that unvaccinated children may catch infectious diseases from vaccinated children. What is true of natural immunity is not true of vaccination.

Adverse Effects of Pertussis and Rubella Vaccines (1991)
Description
Parents have come to depend on vaccines to protect their children from a variety of diseases. Some evidence suggests, however, that vaccination against pertussis (whooping cough) and rubella (German measles) is, in a small number of cases, associated with increased risk of serious illness.
This book examines the controversy over the evidence and offers a comprehensively documented assessment of the risk of illness following immunization with vaccines against pertussis and rubella. Based on extensive review of the evidence from epidemiologic studies, case histories, studies in animals, and other sources of information, the book examines:
The relation of pertussis vaccines to a number of serious adverse events, including encephalopathy and other central nervous system disorders, sudden infant death syndrome, autism, Guillain-Barre syndrome, learning disabilities, and Reye syndrome.
The relation of rubella vaccines to arthritis, various neuropathies, and thrombocytopenic purpura.
The volume, which includes a description of the committee’s methods for evaluating evidence and directions for future research, will be important reading for public health officials, pediatricians, researchers, and concerned parents.

Whooping cough increase related to current vaccine
The move to an artificially created vaccine for whooping cough is behind an increase in cases of the deadly disease in the US, a new study suggests.
The findings highlight the need to do similar research in Australia where whooping cough cases have spiralled upward in the past decade, co-author Associate Professor Manoj Gambhir, from the University of Monash, says.
In 2012 the US saw the highest number of pertussis (whooping cough) cases since 1955.
At the same time there has been a shift in the age group reporting the largest number of cases from adolescents to 7 to 11 year olds.
In the paper, published today in PLOS Computational Biology, Gambhir and colleagues use mathematical modelling of 60 years of pertussis disease data to determine what best explains this increase.

A Change in Vaccine Efficacy and Duration of Protection Explains Recent Rises in Pertussis Incidence in the United States
Published: April 23, 2015
PDF version
Abstract
Over the past ten years the incidence of pertussis in the United States (U.S.) has risen steadily, with 2012 seeing the highest case number since 1955. There has also been a shift over the same time period in the age group reporting the largest number of cases (aside from infants), from adolescents to 7–11 year olds. We use epidemiological modelling and a large case incidence dataset to explain the upsurge. We investigate several hypotheses for the upsurge in pertussis cases by fitting a suite of dynamic epidemiological models to incidence data from the National Notifiable Disease Surveillance System (NNDSS) between 1990–2009, as well as incidence data from a variety of sources from 1950–1989. We find that: the best-fitting model is one in which vaccine efficacy and duration of protection of the acellular pertussis (aP) vaccine is lower than that of the whole-cell (wP) vaccine, (efficacy of the first three doses 80% [95% CI: 78%, 82%] versus 90% [95% CI: 87%, 94%]), increasing the rate at which disease is reported to NNDSS is not sufficient to explain the upsurge and 3) 2010–2012 disease incidence is predicted well. In this study, we use all available U.S. surveillance data to: 1) fit a set of mathematical models and determine which best explains these data and 2) determine the epidemiological and vaccine-related parameter values of this model. We find evidence of a difference in efficacy and duration of protection between the two vaccine types, wP and aP (aP efficacy and duration lower than wP). Future refinement of the model presented here will allow for an exploration of alternative vaccination strategies such as different age-spacings, further booster doses, and cocooning.

FDA NEWS RELEASE – FDA study helps provide an understanding of rising rates of whooping cough and response to vaccination
For Immediate Release: Nov. 27, 2013
A new study is helping to provide a better understanding of vaccines for whooping cough, the common name for the disease pertussis. Based on an animal model, the study conducted by the U.S. Food and Drug Administration (FDA) and published November 25, 2013, in The Proceedings of the National Academy of Sciences, shows that acellular pertussis vaccines licensed by the FDA are effective in preventing the disease among those vaccinated, but suggests that they may not prevent infection from the bacteria that causes whooping cough in those vaccinated or its spread to other people, including those who may not be vaccinated.
While the reasons for the increase in cases of whooping cough are not fully understood, multiple factors are likely involved, including diminished immunity from childhood pertussis vaccines, improved diagnostic testing, and increased reporting. With its own funds plus support from the National Institutes of Health (NIH), the FDA conducted the study to explore the possibility that acellular pertussis vaccines, while protecting against disease, might not prevent infection.

Study- Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model
Although pertussis resurgence is not completely understood, we hypothesize that current acellular pertussis (aP) vaccines fail to prevent colonization and transmission.
To test our hypothesis, infant baboons were vaccinated at 2, 4, and 6 mo of age with aP or whole-cell pertussis (wP) vaccines and challenged with
pertussis at 7 mo. Infection was followed by quantifying colonization in nasopharyngeal washes and monitoring leukocytosis and symptoms. Baboons vaccinated with aP were
protected from severe pertussis-associated symptoms but not from colonization, did not clear the infection faster than naïve animals, and readily transmitted
pertussis to unvaccinated contacts. Vaccination with wP induced a more rapid clearance compared with naïve and aP-vaccinated animals. By comparison, previously infected
animals were not colonized upon secondary infection. Although all vaccinated and previously infected animals had robust serum antibody responses, we found key differences in T-cell immunity.
Previously infected animals and wP-vaccinated animals possess strong pertussis-specific T helper 17 (Th17) memory and Th1 memory,whereas aP vaccination induced a Th1/Th2 response instead. The
observation that aP, which induces an immune response mismatched to that induced by natural infection, fails to prevent colonization or transmission provides a plausible explanation for the
resurgence of pertussis and suggests that optimal control of pertussis will require the development of improved vaccine